Healthtech firm launches world’s first consumer epigenetic testing kit with £1.12m investment

Jan 10, 2019 · bdaily.co.uk

Fy38mvej06qkq0hcuv3qjjszmcp5tentqhuzlfaj

Healthtech company Chronomics has raised seven-figure seed funding and launched the world’s first consumer epigenetic testing kit.

The company has secured over £1.12m funding to date, including significant investment from venture capital firm Anthemis and follow-on backing from SOSV.

Other investors in Chronomics include angel Laurence Garrett, senior partner at Highland Europe.

Chronomics is seeking to revolutionise attitudes towards health management. It offers an epigenetic saliva test that profiles specific lifestyle and environmental indicators and provides accurate insights into an individual’s health, including their biological age and metabolic status.

Read Complete Article

RT @StartupGrindLD: Our health is very important. Yet, government worries more about health-care than health-prevention. How can technology…

The Ultra Low Emission Zone starts in central London in 2 weeks. Petrol cars over 13 years old & diesel cars over 4… https://t.co/3H3IQtKSHW

Host your event within a festival attracting 55,000 attendees from across 90 countries. Get involved in #LTW 2019 →… https://t.co/z8VDtCMsHa

How to charge your iPhone as fast as possible, no matter what charger you have https://t.co/KcmEVDjrKG via @ZDNet & @the_pc_doc

Google Stadia, Apple's new iPads and AirPods, Nokia 9, and Huawei P30 (MobileTechRoundup show #464) https://t.co/PVeC0ji8iV by @palmsolo